Library

| Daily Briefing

Around the nation: Judge blocks nationwide Covid-19 vaccine mandate for federal contractors


A federal judge in Georgia temporarily blocked the Biden administration's Covid-19 vaccine mandate for all federal contractors in the United States, in today's bite-sized hospital and health industry news from Georgia, Maryland, and Washington.

  • Georgia: U.S. District Judge R. Stan Baker on Tuesday temporarily blocked the Biden administration's Covid-19 vaccine mandate that required all federal contractors to be fully vaccinated against the coronavirus by Jan. 18. According to Baker, the challenge to the mandate will likely be upheld by the claim that Biden overstepped his authority with the requirement. "The Court acknowledges the tragic toll that the Covid-19 pandemic has wrought throughout the nation and the globe," Baker wrote. "However, even in times of crisis this Court must preserve the rule of law and ensure that all branches of government act within the bounds of their constitutionally granted authorities." (Kruzel, The Hill, 12/7)
  • Maryland: The University of Maryland Medical System (UMMS) on Monday announced a $5.1 million recruiting initiative to help draw in more nurses and bedside staff as health care workers continue to face increased pressure amid the Covid-19 pandemic. The UMMS Community College Tuition Assistance Inventive Program started in December and will target recent graduates of two-year state schools. "In the spirit of community, we have enhanced our partnerships with community colleges whose health professions programs are an excellent workforce resource, including schools across Maryland and with Delaware Technical Community College," said Lisa Rowen, a registered nurse and UMMS SVP and chief nurse executive. (Christ, Modern Healthcare, 12/6)
  • Washington: University of Washington researchers within a month hope to begin a new clinical trial to determine if psilocybin—in combination with psychotherapy—can help ease the mental health burden placed on clinicians during the Covid-19 pandemic. "Psychedelics kind of give your brain a kind of reset. So that the patterns of thinking, the ruminative cycle that goes round and round in your head, psychedelics disrupt that and give people a chance to kind of see what it's like without that," said Anthony Back, co-director of the university's Center for Excellence in Palliative Care, who will be leading the trial. According to Back, people can use the insights gained during these experiences and ask, "how am I going to move into the future?" (Schubert, Geek Wire, 12/4)

SPONSORED BY

INTENDED AUDIENCE

AFTER YOU READ THIS

AUTHORS

TOPICS

Don't miss out on the latest Advisory Board insights

Create your free account to access 2 resources each month, including the latest research and webinars.

Want access without creating an account?

   

You have 2 free members-only resources remaining this month remaining this month.

1 free members-only resources remaining this month

1 free members-only resources remaining this month

You've reached your limit of free monthly insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox

You've reached your limit of free monthly insights

Become a member to access all of Advisory Board's resources, events, and experts

Never miss out on the latest innovative health care content tailored to you.

Benefits include:

Unlimited access to research and resources
Member-only access to events and trainings
Expert-led consultation and facilitation
The latest content delivered to your inbox
AB
Thank you! Your updates have been made successfully.
Oh no! There was a problem with your request.
Error in form submission. Please try again.